Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT-ITC 2016 | Transplantation today: what are the key messages

Jürgen Kuball • 9 Sep 2016
EBMT-ITC 2016

Jürgen Kuball, MD, PhD from the University Medical Center, Utrecht, Netherlands and EBMT Treasurer, presents some key messages on transplantation which he believes are important in this field at present. Dr Kuball begins by discussing the huge variability in transplant products which are infused in to patients today which he believes to be hugely neglected though it is recognised that this has an impact on patient impact. Dr Kuball goes on to discuss how drugs can be used to ensure patients do not develop graft versus host (GVD) after transplantation based on the patient’s immune constitution. Highlighting the importance of identifying smaller, smarter trials to test such drugs, Dr Kuball believes this is necessary in order to rapidly progress in this field.
Recorded at the 2016 EBMT International Transplant Course (EBMT-ITC) in Barcelona, Spain.

More from Jürgen Kuball

1:12
Dual targeting of the cancer metabolome & stress antigens to improve efficacy of engineered T-cells
Jürgen Kuball • 17 Feb 2024
1:16
An update on the GoCART initiative: GoCART passports & new edition of the EBMT-EHA CAR-T handbook
Jürgen Kuball • 17 Feb 2024
0:48
Novel off-the-shelf CARs: where may these agents fit in the hemonc treatment landscape?
Jürgen Kuball • 10 Feb 2023
0:49
The promise of novel multivalent gamma-delta T-cells in the treatment of cancers
Jürgen Kuball • 10 Feb 2023
The content of VJHemOnc is intended for healthcare professionals